Physician profile
Timothy Scott Albright
NPI 1528421237
$3,444.34
in general payments reported to CMS, 2019-2025
9 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.88 · 2021: $961 · 2022: $1,100 · 2023: $824 · 2024: $191 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $765 · Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $764.95 |
| Food and Beverage | $602.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $1,553.47 | 2021-2025 | |
| Dentsply Sirona INC | $1,145.09 | 2021-2024 | Astra Tech Implant System |
| Salvin Dental Specialties, INC. | $251.76 | 2021 | |
| Nobel Biocare USA | $157.17 | 2022-2023 | Nobelactive |
| Jazz Pharmaceuticals INC. | $122.78 | 2025 | |
| Geistlich Pharma, North America, INC. | $93.09 | 2020-2025 | Biomaterials |
| Henry Schein, INC. | $69.10 | 2025 | |
| Zimvie INC. | $34.29 | 2024 | |
| 3m Company | $17.59 | 2023 | 3m Relyx, 3m Filtek, Scotchbond Universal Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Albright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.